Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

4.44USD
20 Mar 2019
Change (% chg)

-- (--)
Prev Close
$4.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,534
52-wk High
$13.87
52-wk Low
$3.22

Chart for

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $348.98
Shares Outstanding(Mil.): 20.93
Dividend: --
Yield (%): --

Financials

  CRVS.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -2.58 -- --
ROI: -40.42 8.89 13.82
ROE: -40.82 10.00 15.25

Earnings vs. Estimates